The CSNK2A1 Foundation is a non-profit organization dedicated to finding a cure for Okur-Chung neurodevelopmental syndrome (OCNDS) and providing resources and support to families affected by the condition.
The organization has a continual need to communicate crucial medical information about OCND to a wide, multilingual audience.
This requires translating their resources—informational leaflets and educational materials—into multiple languages while ensuring medical accuracy and maintaining a consistent format across different languages.
Solution:
Wolfestone Group provides the CSNK2A1 foundation with comprehensive medical translation services.
Our team of experienced linguists, experienced in medical localization and terminology, translate materials into a range of languages, including Bulgarian, Arabic, Finnish, Czech, Hebrew, and more.
Additionally, we employ multilingual DTP to maintain the original formatting and layout of the leaflets across all languages, guaranteeing a consistent and professional presentation.
A dedicated project manager oversees the entire process, ensuring timely delivery and seamless communication between Wolfestone Group and the CSNKA1 Foundation.
Results:
The translated materials allowed the CSNK2A1 Foundation to reach a broader audience, empowering patients and families globally with vital information about OCNDS.
"Wolfestone Group’s expertise in medical translation has been invaluable to our organization. Accurate translation enables us to provide vital information to a global audience affected by OCNDS.”
This collaboration demonstrates the power of language translation in bridging communication gaps and driving positive change in the medical field.
Ready to break down language barriers in your healthcare communications?
Contact Wolfestone Group today to discuss your specialist medical translation needs.
